Testing effectiveness (Phase 2)Study completedNCT03012165What this trial is testingADX-102 in Subjects With Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Aldeyra Therapeutics, Inc. 154
Not applicableStudy completedNCT01339507What this trial is testingA Patient Reported Ocular Comfort Assessment Comparing Bepreve to LastacaftWho this might be right forAllergic Conjunctivitis Cunningham, Derek N., O.D., P.A. 25
Testing effectiveness (Phase 2)Ended earlyNCT01860664What this trial is testingHydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Koffler Vision Group 15
Testing effectiveness (Phase 2)Looking for participantsNCT06686472What this trial is testingEvaluation of TL-925 for the Treatment of Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Telios Pharma, Inc. 66
Large-scale testing (Phase 3)Study completedNCT05579730What this trial is testingEvaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Bausch & Lomb Incorporated 188
Large-scale testing (Phase 3)Study completedNCT05815758What this trial is testingEvaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic SolutionWho this might be right forAllergic Conjunctivitis Bausch & Lomb Incorporated 512
Not applicableStudy completedNCT01686048What this trial is testingThe Significance of Ambrosia in Allergic Rhinitis and Asthma in IsraelWho this might be right forAllergic RhinitisAsthmaAllergic Conjunctivitis+1 more Meir Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT01275105What this trial is testingA Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)Who this might be right forAllergic Conjunctivitis Eye Therapies, LLC 68
Testing effectiveness (Phase 2)WithdrawnNCT00375596What this trial is testingThe Safety And Effectiveness Of A New Treatment For Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Bausch & Lomb Incorporated
Testing effectiveness (Phase 2)Study completedNCT01344083What this trial is testingComparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic ConjunctivitisWho this might be right forSeasonal Allergic Conjunctivitis Laboratoires Thea 60
Large-scale testing (Phase 3)Study completedNCT02082262What this trial is testingAGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Allergan 140
Not applicableStudy completedNCT02555761What this trial is testingSafety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in KoreaWho this might be right forConjunctivitis, Allergic Allergan 3,423
Not applicableUnknownNCT03820154What this trial is testingDiagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTestWho this might be right forAllergic RhinitisAllergic AsthmaAllergic Conjunctivitis+1 more Prof. Dr. Claus Bachert BVBA 75
Post-approval studies (Phase 4)Study completedNCT01294969What this trial is testingPatient Perception Study for AL-4943AWho this might be right forAllergic Conjunctivitis Alcon Research 47
Large-scale testing (Phase 3)Study completedNCT01743027What this trial is testingEfficacy and Safety of an Ophthalmic Solution in Patients With Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Alcon Research 902
Not applicableStudy completedNCT00609128What this trial is testingEffect of Olopatadine on Allergic Tear MediatorsWho this might be right forAllergic Conjunctivitis University of Wisconsin, Madison 21
Post-approval studies (Phase 4)Study completedNCT01534195What this trial is testingEvaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelWho this might be right forAllergic Conjunctivitis ORA, Inc. 11
Not applicableUnknownNCT04276623What this trial is testingIdentifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentWho this might be right forAtopic Dermatitis UMC Utrecht 150
Post-approval studies (Phase 4)Study completedNCT00133627What this trial is testingKetotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic ConjunctivitisWho this might be right forSeasonal Allergic Conjunctivitis Novartis 229
Post-approval studies (Phase 4)Study completedNCT00534794What this trial is testingStudy of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Merck Sharp & Dohme LLC 79